Topical beta-blockers in patients with co-existing conditions: is this a cause for concern?
Good
C B
CB
D000287:Administration, Topical; D000319:Adrenergic beta-Antagonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use*; D005901:Glaucoma / Q000150:complications* / Q000188:drug therapy* / Q000503:physiopathology; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D009883:Ophthalmic Solutions
D000319:Adrenergic beta-Antagonists; D009883:Ophthalmic Solutions